Ambit Biosciences' Series B Round

Ambit Biosciences raised a round of funding on August 05, 2002.

Ambit Biosciences is a biopharmaceutical company engaged in the development of a robust pipeline of small molecule kinase inhibitors for the treatment of cancer, inflammatory disease and other indicat…

Articles about Ambit Biosciences' Series B Round: